{
    "code": "01046522",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01046522",
    "time": "2022-07-08 03:43:37",
    "許可證字號": "衛署藥製字第046522號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/09\/15",
    "發證日期": "93\/09\/15",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "null",
    "中文品名": "&quot;台耀&quot; 美服普酮",
    "英文品名": "Mifepristone &quot;F.L.&quot;",
    "適應症": "黃體素拮抗劑。",
    "劑型": "040（粉）",
    "包裝": "0.1公斤以上塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "D第四級管制藥品",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "MIFEPRISTONE",
    "限制項目": "01國　產 34第四級管制藥品",
    "申請商名稱": "620102G419  台耀化學股份有限公司",
    "申請商地址": "桃園市蘆竹區和平街36號",
    "主製造廠": [
        {
            "製造廠名稱": "6132051075  台耀化學股份有限公司蘆竹廠",
            "製造廠廠址": "桃園市蘆竹區和平街36、36-1號、油管路2段398號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "29379000103 美服培酮及其衍生物；其鹽類Mifepristone and its derivatives; salts thereof",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200041600",
            "成分名稱": "MIFEPRISTONE",
            "含量描述": "(99-101) (as dried basis)",
            "含量": "",
            "單位": "%"
        }
    ],
    "仿單外盒": [
        {
            "title": "010465220001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01046522&Seq=001&Type=9"
        },
        {
            "title": "01046522_台耀_Mifepristone-104-09-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01046522&Seq=001&Type=8"
        }
    ]
}